Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Anastrozole × Clear all

Sponsor

Conditions

Breast Neoplasms 67 Neoplasms 7 Breast Neoplasms, Male 4 Neoplasm Metastasis 3 Carcinoma, Intraductal, Noninfiltrating 3 Arthralgia 3 Triple Negative Breast Neoplasms 2 Sexual Dysfunction, Physiological 1 Seizures 1 Recurrence 1 Pain 1 Osteoporosis 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Lethal Congenital Contracture Syndrome 2 1 Joint Diseases 1 Invasive Breast Cancer 1 Hypogonadism 1 Granulosa Cell Ovarian Cancer 1 Fractures, Bone 1 Erectile Dysfunction 1 Epilepsy 1 Carcinoma, Non-Small-Cell Lung 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Advanced Metastatic Breast Cancer 1 Advanced Breast Carcinoma 1

Interventions

Carboplatin 21 Cisplatin 14 pembrolizumab 12 Paclitaxel 12 Gemcitabine 12 Pemetrexed 9 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 6 durvalumab 5 Fluorouracil 5 Docetaxel 5 Cyclophosphamide 5 Axitinib 5 Albumin-Bound Paclitaxel 5 osimertinib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Ipilimumab 4 Erlotinib Hydrochloride 4 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 vosaroxin 2 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡